Health
Cigarette maker BAT announces US vaccine trial launch – Medical Xpress
British cigarette maker BAT said Wednesday that its US biotech division Kentucky BioProcessing will launch trials of a potential coronavirus vaccine, developed…
British cigarette maker BAT said Wednesday that its US biotech division Kentucky BioProcessing will launch trials of a potential coronavirus vaccine, developed using tobacco plant technology.
The group said the US Food and Drug Administration has approved its application for a vaccine candidate, paving the way for an initial phase one clinical trial in 180 adults.
Study results are expected in mid-2021, when the group hopes to progress to a phase two trial on the project, which is being run on a…
-
Noosa News22 hours agoFull house as Minister shares vision for Sunshine Coast transport
-
Business20 hours agoWhy I’d buy these top ASX 200 shares next
-
Noosa News19 hours agoDocPlay Is Streaming 11 Documentaries About Indigenous and Torres Strait Islander Culture for Free for NAIDOC Week 2025
-
Business17 hours ago10 reasons to buy and hold this tech stock forever